Winton Group LTD Coherus Bio Sciences, Inc. Transaction History

Winton Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$10.92 - $16.41 $303,150 - $455,558	-27,761 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$15.81 - $18.99 $513,477 - $616,757	-32,478 Reduced 53.92%	27,761 $443,000
Q3 2021 Oct 28, 2021	SELL	$12.68 - $17.79 $208,230 - $292,147	-16,422 Reduced 21.42%	60,239 $968,000
Q2 2021 Aug 10, 2021	BUY	$12.95 - $15.41 $111,590 - $132,787	8,617 Added 12.66%	76,661 $1.06 Million
Q1 2021 Jul 21, 2021	BUY	$14.42 - $21.39 $168,843 - $250,455	11,709 Added 20.78%	68,044 $994,000
Q4 2020 Feb 12, 2021	SELL	$16.56 - $18.94 $971,409 - $1.11 Million	-58,660 Reduced 51.01%	56,335 $979,000
Q3 2020 Oct 30, 2020	BUY	$17.41 - $19.89 $1.1 Million - $1.26 Million	63,271 Added 122.32%	114,995 $2.11 Million
Q2 2020 Aug 05, 2020	BUY	$14.43 - $19.16 $746,377 - $991,031	51,724 New	51,724 $924,000

137

78M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $96.4M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.